Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
about
Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?Moxifloxacin dosing in post-bariatric surgery patients.In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.Is selection relevant in the evolutionary emergence of drug resistance?The changing face of antibiotic prescribing: the mutant selection window.Optimization of antibiotic dosing schedules in the light of increasing antibiotic resistance.Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infectionRecent developments in the clinical activity of topoisomerase-1 inhibitors.Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates.Mutant selection window hypothesis updated.Optimizing drug exposure to minimize selection of antibiotic resistance.Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection modelUsing In Vitro Dynamic Models To Evaluate Fluoroquinolone Activity against Emergence of Resistant Salmonella enterica Serovar Typhimurium.Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: Part I gram positive bacteria.Species differences in ciprofloxacin resistance among Gram-negative bacteria: can "anti-mutant" ratios of the area under the concentration-time curve to the MIC be achieved clinically?Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by Using In Vitro Dynamic Models.Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window.Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.Are ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance? Pseudomonas aeruginosa bloodstream infection in elderly patients as a simulation case study.Pharmacodynamic assessment based on mutant prevention concentrations of fluoroquinolones to prevent the emergence of resistant mutants of Streptococcus pneumoniae.Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin.Efficacy and safety of adjunctive local moxifloxacin delivery in the treatment of periodontitis.Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.Pharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of After Repeated Administration of DanofloxacinRelationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro modelSusceptibility ofStreptococcus pneumoniaeclinical isolates to quinolones
P2860
Q28552950-9CCFCEF0-2096-434D-9909-B709240753E3Q34209532-4FEF05D4-8480-4224-8BA7-B7B2A7D9DBE1Q34788573-BAB624A8-FF13-4C8D-92B5-E56CD6BF638CQ35826386-66E588F9-D5FB-47D6-A569-900DE55B83FCQ35875929-1C9A5E9C-B4A9-4A08-B2CB-0D2327788BC3Q35917371-DF4FD9A9-2625-4650-AF14-EF3F2B942077Q36095024-B729A82D-44DA-446E-983A-B3E4E9EA67E2Q36234871-E4ED8181-6655-41F3-B17A-E5D237FC826DQ36505518-3723A3BC-51C6-4386-81DB-8034507019F2Q36684184-237B5105-464C-4FC5-AC52-31F7B1E99E6EQ36728061-1C48A7CD-F4E4-485F-93AA-017ACFE9C16DQ36903693-0FE72004-8715-451D-A907-4398C74127C4Q37274635-36364114-8929-40B7-A59E-0E1A85E8E568Q37613055-B4FB244C-66C3-4470-9149-AF36F429E34DQ38692072-D275B999-2B3F-400C-8BC7-457875CD8EAFQ38740127-6654A8BA-BEA7-4C77-9084-287F7D3AC3E1Q38740720-19740AA5-449B-4002-B099-C6A6D6D7BB41Q38899404-BCD3B75A-1C7B-44DB-89C0-176FCC25118AQ39108922-23255A63-69FD-4BD9-B24E-DDB7A5D37703Q40253055-47C72F21-BA87-4CA3-816D-31D33A0EAAD4Q40346786-4CF7F302-53AC-48AE-A5DA-1BED76595BB3Q40982184-7DF18E05-1EC1-4D4C-9DE1-AE66F537E5C2Q41854694-B0A6DF64-3918-466D-B53C-A7EEAA45AD10Q42861027-C13B458E-E03E-4657-82BC-4DA459DDD714Q43810745-F309AC4D-F3F8-4A90-BCA2-28902E691B27Q43988363-04161ABC-A272-4E25-B87E-62F1E7463F1FQ49578631-82FB18CD-FB65-4CC9-9F2F-F3253599815EQ58123039-9F91FA22-1ABC-402F-BF8A-9F9ADDA8AAC7Q58696539-ACDB855D-8138-478C-8D7A-85EB1EFD99AAQ58864097-1D9BD45A-E098-4737-8500-A7C9DB4CBEEE
P2860
Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Emergence of resistant Strepto ...... equency and bacterial killing.
@en
Emergence of resistant Strepto ...... equency and bacterial killing.
@nl
type
label
Emergence of resistant Strepto ...... equency and bacterial killing.
@en
Emergence of resistant Strepto ...... equency and bacterial killing.
@nl
prefLabel
Emergence of resistant Strepto ...... equency and bacterial killing.
@en
Emergence of resistant Strepto ...... equency and bacterial killing.
@nl
P2093
P356
P1476
Emergence of resistant Strepto ...... equency and bacterial killing.
@en
P2093
Alexander A Firsov
Deborah Gilbert
Irene Yu Lubenko
Karl Drlica
Kelly Simmons
Stephen H Zinner
P304
P356
10.1093/JAC/DKG401
P407
P50
P577
2003-09-01T00:00:00Z